Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial

Fig. 4

Responder analyses for normative scores and patient acceptable symptom state (PASS). a Percentage of patients reporting scores equal to or greater than normative values on the functional assessment of chronic illness therapy-fatigue (FACIT-F) and Short Form 36 (SF-36) at baseline. b Percentage of patients reporting scores equal to or greater than PASS thresholds at baseline. c Percentage of patients reporting scores equal to or greater than normative values on the FACIT-F and SF-36 at week 24. d Percentage of patients reporting scores equal to or greater than PASS thresholds at week 24. PF physical functioning, RP role physical, BP body pain, GH general health, VT vitality, SF social functioning, RE role emotional, MH mental health

Back to article page